PMID- 10066434 OWN - NLM STAT- MEDLINE DCOM- 19990413 LR - 20161124 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 256 IP - 1 DP - 1999 Mar 5 TI - In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination. PG - 121-6 AB - Activation of the transcriptional factor NF-kappaB is triggered by signal-dependent degradation of its inhibitor protein IkappaB through the ubiquitin (Ub)-proteasome pathway. We found here that a phosphorylated IkappaBalpha immunoprecipitated (IP-pIkappaBalpha) from the crude extract of HeLa cells which had been treated with tumor necrosis factor-alpha (TNFalpha) caused a dramatic ubiquitination of itself, termed autoubiquitination, when incubated with ATP, Ub, and E1-activating and E2-conjugating enzymes. IP-pIkappaBalpha also catalyzed ubiquitination of an in vitro synthesized 35S-IkappaBalpha previously phosphorylated by IkappaB-kinase (IKK) which is referred to as transubiquitination. No appreciable activity of auto- and transubiquitination was observed in an unphosphorylated IP-IkappaBalpha. Moreover, the putative IkappaBalpha-Ub ligase (IkappaBalpha-E3) present in HeLa cell cytosol associated in vitro with an IKK-phosphorylated recombinant IkappaBalpha, a process independent of NF-kappaB binding to IkappaBalpha or TNFalpha stimulation. Replacement of the two Ser residues at positions 32 and 36 corresponding to IKK phosphorylation sites by Ala resulted in almost complete prevention of binding of an IkappaBalpha-E3 to IkappaBalpha. These results indicate that phosphorylation of IkappaBalpha is necessary and sufficient for recruitment of this IkappaBalpha-E3 to associate with IkappaBalpha. CI - Copyright 1999 Academic Press. FAU - Suzuki, H AU - Suzuki H AD - Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Ibaraki, Tsukuba-shi, 305-8585, Japan. FAU - Chiba, T AU - Chiba T FAU - Kobayashi, M AU - Kobayashi M FAU - Takeuchi, M AU - Takeuchi M FAU - Furuichi, K AU - Furuichi K FAU - Tanaka, K AU - Tanaka K LA - eng PT - Journal Article PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (DNA-Binding Proteins) RN - 0 (I-kappa B Proteins) RN - 0 (NF-kappa B) RN - 0 (NFKBIA protein, human) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Transcription Factor RelA) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (Ubiquitins) RN - 139874-52-5 (NF-KappaB Inhibitor alpha) RN - 17885-08-4 (Phosphoserine) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 2.3.2.23 (Ubiquitin-Conjugating Enzymes) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.7.11.1 (Protein-Serine-Threonine Kinases) RN - EC 2.7.11.10 (CHUK protein, human) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - EC 2.7.11.10 (IKBKB protein, human) RN - EC 2.7.11.10 (IKBKE protein, human) RN - EC 6.- (Ligases) SB - IM MH - Adenosine Triphosphate/metabolism MH - Amino Acid Substitution MH - Animals MH - Blotting, Western MH - DNA-Binding Proteins/chemistry/genetics/*metabolism MH - Enzyme Activation/drug effects MH - HeLa Cells MH - Humans MH - I-kappa B Kinase MH - *I-kappa B Proteins MH - Ligases/*metabolism MH - NF-KappaB Inhibitor alpha MH - NF-kappa B/metabolism MH - Phosphorylation/drug effects MH - Phosphoserine/metabolism MH - Precipitin Tests MH - Protein Binding/drug effects MH - Protein-Serine-Threonine Kinases/*metabolism MH - Recombinant Fusion Proteins/chemistry/genetics/metabolism MH - Signal Transduction/drug effects MH - Time Factors MH - Transcription Factor RelA MH - Tumor Necrosis Factor-alpha/pharmacology MH - Ubiquitin-Conjugating Enzymes MH - Ubiquitin-Protein Ligases MH - Ubiquitins/*metabolism EDAT- 1999/03/06 00:00 MHDA- 1999/03/06 00:01 CRDT- 1999/03/06 00:00 PHST- 1999/03/06 00:00 [pubmed] PHST- 1999/03/06 00:01 [medline] PHST- 1999/03/06 00:00 [entrez] AID - S0006-291X(99)90296-6 [pii] AID - 10.1006/bbrc.1999.0296 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 1999 Mar 5;256(1):121-6. doi: 10.1006/bbrc.1999.0296.